GRECCAR2 trial: details worthy of more attention

Affiliations

¹ Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Clinical Statistics Center, Fudan University Shanghai Cancer Center, Shanghai, China.
² Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
³ Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: leoon.zhu@gmail.com.

Comment

Huixun Jia et al. Lancet. 2018.

. 2018 Jan 13;391(10116):122.

doi: 10.1016/S0140-6736(18)30015-1.

¹ Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Clinical Statistics Center, Fudan University Shanghai Cancer Center, Shanghai, China.
² Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
³ Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: leoon.zhu@gmail.com.

No abstract available

Comment in

GRECCAR2 trial: details worthy of more attention - Authors' reply.
Rullier E, Vendrely V, Denost Q, Asselineau J, Doussau A. Rullier E, et al. Lancet. 2018 Jan 13;391(10116):122-123. doi: 10.1016/S0140-6736(18)30016-3. Lancet. 2018. PMID: 29353619 No abstract available.

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
Rullier E, Rouanet P, Tuech JJ, Valverde A, Lelong B, Rivoire M, Faucheron JL, Jafari M, Portier G, Meunier B, Sileznieff I, Prudhomme M, Marchal F, Pocard M, Pezet D, Rullier A, Vendrely V, Denost Q, Asselineau J, Doussau A. Rullier E, et al. Lancet. 2017 Jul 29;390(10093):469-479. doi: 10.1016/S0140-6736(17)31056-5. Epub 2017 Jun 7. Lancet. 2017. PMID: 28601342 Clinical Trial.